Abstract

Interleukin-1β (IL-1β) is a key effector of the inflammasome complex in response to pathogens and danger signals. Although it is well known that assembly of the inflammasome triggers proteolytic cleavage of the biologically inactive precursor pro-IL-1β into its mature secreted form, the mechanism by which human cytomegalovirus (HCMV) regulates IL-1β production via the inflammasome is still poorly understood. Here, we show that the infection of human foreskin fibroblasts (HFFs) with a mutant HCMV lacking the tegument protein pp65 (v65Stop) results in higher expression levels of mature IL-1β compared to its wild-type counterpart, suggesting that pp65 mediates HCMV immune evasion through downmodulation of IL-1β. Furthermore, we show that enhanced IL-1β production by the v65Stop mutant is due in part to induction of DNA binding and the transcriptional activity of NF-κB. Lastly, we demonstrate that HCMV infection of HFFs triggers a non-canonical IL-1β activation pathway where caspase-8 promotes IL-1β maturation independently of caspase-1. Altogether, our findings provide novel mechanistic insights into the interplay between HCMV and the inflammasome system and raise the possibility of targeting pp65 to treat HCMV infection.

Highlights

  • Human cytomegalovirus (HCMV) is a ubiquitous opportunistic β-herpesvirus that is found in 50–90% of the population worldwide

  • IL-1β Induction upon human cytomegalovirus (HCMV) Infection is Inhibited by the HCMV Tegument Protein pp65 in an NF-κB

  • Our findings add novel functional and mechanistic insights into the role that is played by the HCMV tegument protein pp65 in HCMV immune evasion

Read more

Summary

Introduction

Human cytomegalovirus (HCMV) is a ubiquitous opportunistic β-herpesvirus that is found in 50–90% of the population worldwide. Despite the occurrence of periodic reactivation and subsequent virus-shedding episodes, HCMV infection is asymptomatic in immunocompetent hosts. Innate immunity is the first line of defense against HCMV, allowing the host to rapidly mount an antiviral response upon viral infection [3,4]. This is prominent during the perinatal period when the immune system is still immature [3]. This innate response is mediated by type I and Viruses 2018, 10, 567; doi:10.3390/v10100567 www.mdpi.com/journal/viruses

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.